Align Technology's Q2 2026 Playbook: Clear Aligner Momentum Amid FX Drift, with an Ear to EPS and Revenue Forecast

Quarter in numbers: revenue growth centers the story

Align Technology reported total revenues of $1,056.2 million for the quarter, up 1.5% sequentially and up 4.3% year-over-year. The headline is the resilience of the top line even as the sales mix shifts and currency moves blur the underlying momentum. Within the composition, Clear Aligner revenues stood at $870.9 million, up 8.2% year-over-year, with shipments totaling 691.8 thousand cases—an international growth driver supported by stable North American performance.

The Imaging Systems and CAD/CAM Services segment contributed about $185.3 million, reflecting softness in the capital equipment market and a shift toward lower-priced scanners and flexible financing, including leasing and rental programs.

Margins under pressure and the non-GAAP cushion

On the margin front, GAAP gross margin came in at 71.7%, with non-GAAP gross margin around 72.3%. The gap points to foreign exchange headwinds of roughly 0.2 percentage points sequentially and about 0.8 percentage points year-over-year, plus the broader mix effects from a heavier presence of lower-priced scanners and financing mix. The operating margin printed at 14.6% (non-GAAP 22.9%), with currency and mix headwinds again cited as the drag versus a year ago.

The notes hint at ongoing non-GAAP adjustments, but the excerpt does not show an EPS figure or a formal EPS consensus here. Investors will be scanning for the usual telltales—EPS and EPS consensus against the company’s own guidance, and whether there was an earnings surprise versus sell-side estimates. In other words, the market is likely to test whether the margin strength can keep pace with FX pressure and the capital equipment cycle.

Drivers, risks, and what it portends for the sector

The quarterly narrative underscores a few durable themes. First, the Clear Aligner franchise remains the growth engine, with double-digit international momentum and steady volume growth in the core markets. That said, the equipment side—Imaging Systems and CAD/CAM services—still faces cyclical headwinds tied to capital expenditure cycles, which have softened in the near term and are being cushioned by flexible financing programs.

FX remains a meaningful, non-trivial risk. The report quantifies roughly a $6.1 million adverse impact sequentially from currency and a $12.5 million favorable impact year-over-year, illustrating how foreign exchange can swing both directions over a few quarters. If the currency backdrop persists, even a healthy revenue trajectory might not translate into a clean margin expansion, which will be a critical test for ALGN’s operating leverage.

For peers in the dental tech ecosystem, the message is twofold: (1) growth remains tied to patient access to orthodontic solutions and international expansion, and (2) the mix of financing solutions—leases and rentals—becomes a material strategic variable that can dampen or amplify revenue visibility. The balance between selling high-margin software-enabled services and cycling through capital equipment purchases will be watched closely.

What investors will watch next: EPS, guidance, and the revenue forecast

The publicly disclosed portion of the release emphasizes revenue, volume, and margins. While an explicit EPS figure isn’t shown in this excerpt, the market’s focus will likely turn to the EPS result and how it stacks up against consensus estimates. If the reported EPS diverges from expectations, expect a meaningful re-pricing of ALGN shares, even if the revenue trend remains solid.

A pivotal question for the next communication is the revenue forecast, i.e., the forward-looking guidance that ties into long-horizon margin expectations and capital spending cadence. A stable or improving revenue forecast, supported by growing shipments in Clear Aligner and a favorable mix of services, would help offset FX headwinds and support a constructive view on EPS trajectory.

In short, ALGN’s near-term stock story will hinge on whether the earnings surprise lands on the upside or topside margin improvement remains achievable under currency pressure, and whether the EPS consensus can be nudged higher by a stronger demand signal and a more favorable financing mix.

Bottom line: resilience with a currency-shaped hitch

Align Technology’s Q2 2026 results show a company delivering growth in its core product with a cost of capital exposure that isn’t trivial. The mix of robust Clear Aligner volumes and international expansion provides a solid runway, but FX and capital equipment dynamics keep margins from expanding as quickly as the revenue may imply. For the sector, the quarter offers a pragmatic reminder: the health of growth engines (Clear Aligner demand) must be weighed against the choke points of financing models and currency swings, which can tilt the earnings plane even when the passenger count—the shipments—looks healthy.

For investors, the next act will hinge on the EPS line, the EPS consensus, and how closely the updated revenue forecast aligns with the reality of a mixed capital equipment cycle. If ALGN can translate the volume strength into sustained margin discipline and a clearer path to non-GAAP profitability, the stock could start to reflect the underlying operating leverage more plainly—one more reminder that in dental tech, the smile depends on both the teeth and the financing.